Skip to main content
OpenTrials
Completed

NCT Number: NCT06121115

Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit

This is a single-center study retrospectively evaluating a local clinical routine to administer norepinephrine in midline catheters, with regard to complications and patient outcomes

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Septic Shock Cardiovascular Diseases Embolism and Thrombosis Hypotension Hypotension and Shock Infections Inflammation Norepinephrine Adverse Reaction Pathologic Processes Pathological Conditions, Signs and Symptoms Sepsis Shock Shock, Septic Systemic Inflammatory Response Syndrome Thrombosis Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Skåne University Hospital

Malmö, Sweden

About this study

Se attached study protocol

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Administration of norepinephrine in a midline catheter in an intermediary care unit
  • In Skåne university hospital
  • From 2019 to 2023-03-31

Exclusion criteria

  • Patients who have actively disabled review of their electronic medical record

Treatment and study plan

norepinephrine

Drug

Norepinephrine administered in midline catheter according to clinical routine

Other names: Vasopressors

Primary outcomes

  1. Proportion of patients with a major complication of norepinephrine administration in midline

    Time frame: day 30

    extravasation of norepinephrine, midline-associated bloodstream infection, thrombosis

Secondary outcomes

  1. Proportion of patients with a minor complication of norepinephrine administration in midline

    Time frame: day 30

    infiltration, occlusion of midline, dislodgement, leakage, other

  2. Proportion of patients receiving a CVC after midline

    Time frame: day 30

    Has the patient received central line after midline placement

  3. Proportion of patients with different intermediary care unit outcomes

    Time frame: day 30

    Where did the patient go after intermediary care? discharged / escalated to the ICU / deceased

Sponsors and collaborators

Lead sponsor

Region Skane

Other

Registry information

Official study title

Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit - a Retrospective Study of Complications and Patient Outcomes

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Nov 7, 2023
Registry last updated
Mar 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.